Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03965195
What this trial is testing

Recombinant Influenza Vaccination in U.S. Nursing Homes

Who this might be right for
InfluenzaInfluenza -Like IllnessInfluenza, Human
Insight Therapeutics, LLC 1,989
Large-scale testing (Phase 3)Study completedNCT03314662
What this trial is testing

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Who this might be right for
Influenza, Human
Seqirus 1,778
Post-approval studies (Phase 4)Study completedNCT05028361
What this trial is testing

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Who this might be right for
Quality of LifeInjection Site ReactionAdverse Drug Event+1 more
Duke University 348
Early research (Phase 1)Active Not RecruitingNCT06622590
What this trial is testing

Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Influenza, HumanInfluenza aInfluenza Type B+1 more
Institute of Medical Biology, Chinese Academy of Medical Sciences 180
Large-scale testing (Phase 3)Study completedNCT02550197
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 300
Not applicableStudy completedNCT03438487
What this trial is testing

Flucelvax (TIVc or QIVc) Pregnancy Registry

Who this might be right for
Influenza, HumanPregnancyBirth Defect
Seqirus 692
Large-scale testing (Phase 3)Study completedNCT02677493
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

Who this might be right for
Influenza
Il-Yang Pharm. Co., Ltd. 1,794
Large-scale testing (Phase 3)Study completedNCT02451358
What this trial is testing

Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 400
Post-approval studies (Phase 4)Study completedNCT03308825
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Who this might be right for
InfluenzaFlu
Sanofi Pasteur, a Sanofi Company 240
Large-scale testing (Phase 3)Study completedNCT01481454
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,701
Large-scale testing (Phase 3)Study completedNCT06060457
What this trial is testing

Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,900
Not applicableStudy completedNCT02554409
What this trial is testing

Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry

Who this might be right for
PregnancyInfluenza
Sanofi Pasteur, a Sanofi Company 87
Not applicableEnded earlyNCT01997450
What this trial is testing

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Who this might be right for
Influenza Vaccine Effectiveness
MedImmune LLC 4,121
Testing effectiveness (Phase 2)Study completedNCT04782323
What this trial is testing

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Who this might be right for
Influenza
Seqirus 839
Post-approval studies (Phase 4)Study completedNCT01827462
What this trial is testing

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Who this might be right for
Influenza
Stanford University 136
Testing effectiveness (Phase 2)Study completedNCT04576702
What this trial is testing

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Who this might be right for
InfluenzaHuman
Seqirus 471
Large-scale testing (Phase 3)Study completedNCT03282240
What this trial is testing

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 2,670
Post-approval studies (Phase 4)Study completedNCT05050318
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Post-approval studies (Phase 4)Study completedNCT02967393
What this trial is testing

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

Who this might be right for
Asthmatic
Vanderbilt University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02233816
What this trial is testing

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 300
Next Page